NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Activity
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

37 hedge funds and large institutions have $92.1M invested in NKGen Biotech, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$13.1M
2
HCM
2
Highbridge Capital Management
New York
$10.9M
3
RCM
3
Radcliffe Capital Management
Pennsylvania
$5.81M
4
6CM
4
683 Capital Management
New York
$4.85M
5
FTCM
5
Fir Tree Capital Management
New York
$4.85M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$910K 93,900 +93,900 New
GCIA
27
Gabelli & Co Investment Advisers
New York
$835K 86,200 +86,200 New
EAM
28
Exos Asset Management
New York
$678K 70,000 +70,000 New
TI
29
Telemetry Investments
New York
$524K 54,061 +54,061 New
Marshall Wace
30
Marshall Wace
United Kingdom
$490K 50,537 +50,537 New
EIP
31
Easterly Investment Partners
Massachusetts
$485K 50,000 +50,000 New
Walleye Trading
32
Walleye Trading
New York
$349K 36,000 +36,000 New
HighTower Advisors
33
HighTower Advisors
Illinois
$327K 33,900 +33,900 New
FBCM
34
Fort Baker Capital Management
California
$240K 24,714 +24,714 New
SSA
35
Schonfeld Strategic Advisors
New York
$140K 14,451 +14,451 New
JPMorgan Chase & Co
36
JPMorgan Chase & Co
New York
$80K 8,237 +8,237 New
Walleye Capital
37
Walleye Capital
New York
$508 52,397 +52,397 New
CFGS
38
Concourse Financial Group Securities
Alabama
– – – –
1
2